Skip to main content
. 2020 Feb 3;7(1):ENEURO.0081-19.2020. doi: 10.1523/ENEURO.0081-19.2020

Table 6.

Statistics for the data shown in Figures 9, 10

Figure Statistical test Statistics output N
Fig. 9    
mGPSC frequency:
DMSO × CNO
ANOVA F(1,30) = 5.642,p = 0.024 CNO: 10 neurons, 3 mice
mGPSC amplitude:
DMSO × CNO
ANOVA F(1,30) = 2.205,p = 0.148
mGPSC frequency:
DPCPX × DPCPX + CNO
ANOVA F(1,10) = 0.7, p = 0.422 CNO + DPCPX: 12 neurons, 4 mice
mGPSC amplitude:
DPCPX × DPCPX + CNO
ANOVA F(1,10) = 2.515,p = 0.144
mGPSC frequency:
DMSO × CNOwoDREADD
ANOVA F(1,30) = 1.334,
p = 0.257
CNOwoDREADD:
10 neurons, 3 mice
mGPSC amplitude:
DMSO × CNOwoDREADD
ANOVA F(1,30) = 0.731, p = 0.4
Fig. 10    
Phase shift: slice × treatment
(control/WIN/DPCPX/WIN+DPCPX)
Repeated measures ANOVA F(3,28) = 15.014,
p < 0.001
8 mice per group
Period change WIN experiments:
pre and post only
Repeated Measures ANOVA F(1,28) = 0.163,
p = 0.69
8 mice per group
Period change WIN experiments:
pre and post × treatment
Repeated measures ANOVA F(1,28) = 0.860,
p = 0.474
8 mice per group
Phase shift: slice × treatment (adenosine/control) Repeated measures ANOVA F(1,13.38) = 5.663,
p = 0.032
7–11 mice per group
Period change adenosine:
pre and post only
Repeated measures ANOVA F(1,16) = 10.816,
p = 0.005
7–11 mice per group
Period change adenosine:
pre and post × treatment
Repeated measures ANOVA F(1,16) = 0.568,
p = 0.462
7–11 mice per group